B of A Securities Maintains Buy on Biohaven, Raises Price Target to $62
B of A Securities Maintains Buy on Biohaven, Raises Price Target to $62
美銀證券維持對biohaven的買入評級,將目標股價上調至62美元
B of A Securities analyst Jason Gerberry maintains Biohaven (NYSE:BHVN) with a Buy and raises the price target from $52 to $62.
美銀證券分析師Jason Gerberry 維持biohaven(紐交所:BHVN)的買入評級,並將價格目標從52美元上調至62美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。